PANCREAS ADENOCARCINOMA
Clinical trials for PANCREAS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREAS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREAS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chemo sequence aims to shrink pancreatic tumors enough for surgery
Disease control Recruiting nowThis study is for people with pancreatic cancer that is either borderline or locally advanced, meaning it has not spread far but is hard to remove surgically. Researchers want to see if giving two different chemotherapy combinations one after the other can shrink the tumor enough…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
New combo approach aims to slash deadly leaks after pancreatic surgery
Disease control Recruiting nowThis study tests whether giving a short course of two medicines (hydrocortisone and octreotide) plus using a patch made from the patient's own tissue during surgery can lower the risk of serious complications after Whipple surgery. The trial includes 400 adults with a small pancr…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
New hope for advanced stomach and pancreatic cancers: extra attack when DNA levels hit zero
Disease control Recruiting nowThis study tests whether adding a second round of targeted treatment (called cytoreductive intervention) after standard chemotherapy can help people with advanced upper GI cancers live longer without the disease getting worse. It is for patients whose cancer has spread but whose …
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New combo therapy aims to boost pancreatic cancer surgery success
Disease control Recruiting nowThis study tests whether giving chemotherapy and radiation before surgery can help surgeons remove all of the pancreatic cancer. About 30 adults with early-stage, removable pancreatic cancer will receive the drugs gemcitabine and nab-paclitaxel plus targeted radiation, then surge…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Loma Linda University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New chemo rotation may shrink pancreatic tumors enough for surgery
Disease control Recruiting nowThis study tests whether switching between two different chemotherapy combinations can help people with borderline resectable pancreatic cancer. The goal is to shrink the tumor enough for successful surgery and to improve survival without the cancer coming back. About 35 adults w…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New antibody combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called ZM008, alone and with another drug (toripalimab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and check for side effects. About 100 adults with canc…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Zumutor Biologics Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can your Tumor's DNA predict chemo success? new study aims to find out
Disease control Recruiting nowThis study looks at how the genetic makeup of pancreatic cancer affects response to FOLFIRINOX chemotherapy given before surgery. About 45 adults with non-metastatic pancreatic cancer will receive chemo, then have their tumors analyzed. The goal is to see if certain tumor types r…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 05, 2026 11:57 UTC
-
Scientists hunt for genetic clues to stop muscle loss in pancreatic cancer
Knowledge-focused Recruiting nowThis study looks at genetic differences in people with pancreatic cancer to understand why many develop severe muscle wasting (cachexia). Researchers will collect blood samples from 100 patients and track weight loss over three months. The goal is to find genetic markers that cou…
Matched conditions: PANCREAS ADENOCARCINOMA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 03:14 UTC